🇰🇷 OPDIVO QVANTIG in South Korea

OPDIVO QVANTIG (HYALURONIDASE-NVHY) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

OPDIVO QVANTIG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in South Korea

Frequently asked questions

Is OPDIVO QVANTIG approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for OPDIVO QVANTIG in South Korea?

BRISTOL-MYERS SQUIBB is the originator. The local marketing authorisation holder may differ — check the official source linked above.